Adicet Bio
ACET
54 hedge funds and large institutions have $41.6M invested in Adicet Bio in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
32% more capital invested
Capital invested by funds: $31.5M → $41.6M (+$10.2M)
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
10% more funds holding
Funds holding: 49 → 54 (+5)
0.04% less ownership
Funds ownership: 3.9% → 3.86% (-0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$497K |
| 2 |
Two Sigma Investments
New York
|
+$252K |
| 3 |
Two Sigma Advisers
New York
|
+$158K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$141K |
| 5 |
Jane Street
New York
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.03M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$329K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$180K |
| 4 |
LM
Luminus Management
Houston,
Texas
|
-$177K |
| 5 |
Millennium Management
New York
|
-$19.4K |
ACET Hedge Fund Activity: Q3 2025 in Review
54 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q3 2025, worth a combined $41.6M — up 32% from $31.5M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACET positions and 7 closed out — a net gain of 5 holders — while 13 added to existing stakes and 11 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $497K. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $1.03M.
- 54 institutional investors held Adicet Bio (ACET) as of Q3 2025, up from 49 in Q2 2025.
- Funds reported $41.6M of Adicet Bio stock for Q3 2025, up 32% quarter-over-quarter.
- 12 funds opened new Adicet Bio positions in Q3 2025 and 7 closed out, a net change of +5 holders.
- The largest Adicet Bio buyer in Q3 2025 was Renaissance Technologies, an estimated $497K added.
- The largest Adicet Bio seller in Q3 2025 was Schonfeld Strategic Advisors, an estimated $1.03M sold.
Based on aggregated 13F filings for Q3 2025.